Bachem Holding AG is a prominent name in the biotechnology and pharmaceutical industry, specializing in the development and manufacture of peptides and oligonucleotides. These are complex organic comp... Bachem Holding AG is a prominent name in the biotechnology and pharmaceutical industry, specializing in the development and manufacture of peptides and oligonucleotides. These are complex organic compounds crucial for the creation of innovative therapeutics and diagnostics. Bachem's operations are integral to the pharmaceutical sector, providing specialist active pharmaceutical ingredients (APIs) and related services. The company's comprehensive offering includes full-spectrum support from initial research and development stages to full-scale production, underpinned by a commitment to quality and regulatory compliance. With a global presence, Bachem serves a wide array of clients across various pharmaceutical companies, ensuring the availability of critical components for drug development worldwide. Founded in 1971 and headquartered in Bubendorf, Switzerland, Bachem has established itself as a key player in facilitating advancements in medical treatments through its specialized biochemical expertise.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Bachem Holding is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Bachem Holding is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Bachem Holding's data?

Start your 30-day free trial to request a data review for Bachem Holding.

Start Free Trial

Legal Center Contact Us